PFL Investors Overview

Organization Details & Summary of Results

Innovate | Lead | Prosper

Disclosures under Regulation 46 and 62 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015

Poonawalla Press release

Poonawalla Fincorp Q1 Results: Net Profit Jumps 45% To Rs 292 Crore

Why Poonawalla Fincorp Arrow Logo

Poonawalla Fincorp Limited is a Cyrus Poonawalla group promoted NBFC-ND-SI that focuses on consumer and small business financing. The Company started operations nearly three decades back and is listed on the BSE Limited and the National Stock Exchange in India.

The Cyrus Poonawalla Group of Companies, headquartered in Pune, are a diversified group with business interests that include Pharmaceuticals & Biotechnology, Financial Services, Clean Energy, Hospitality & Realty and Aviation. Serum Institute of India Private Limited, the group’s flagship company, is the world’s largest manufacturer of vaccines, supplying to Indian as well as global markets.

This section is dedicated to all financial information of our company – Investor Presentations, Company announcements, Annual Reports and statutory disclosures to stock exchanges and regulators. Stay tuned to this section for the latest information on all these.

Summary of Results Arrow Logo

HIGHLIGHTS Q1 FY25

AUM Logo AUM
₹26,972 Cr
AUM Logo NII
₹676 Cr
NET Logo PPoP
₹432 Cr
PAT Logo PBT
₹390 Cr
ROA Logo PAT
₹292 Cr
NET Logo GNPA
0.67%
GNPA Logo NNPA
0.32%
NNPA Logo ROA
4.62%
NET Logo CAR
31.57%
Contact Us logo Quick Apply CIBIL Score logo Free CIBIL Whatsapp logo Connect on WhatsApp